Enables oxysterol binding activity; protein kinase A catalytic subunit binding activity; and protein sequestering activity. Involved in several processes, including regionalization; regulation of animal organ morphogenesis; and regulation of gene expression. Acts upstream of or within several processes, including nervous system development; positive regulation of cell population proliferation; and regionalization. Located in several cellular components, including centriole; ciliary membrane; and endoplasmic reticulum-Golgi intermediate compartment. Is expressed in several structures, including 1st branchial arch; alimentary system; central nervous system; genitourinary system; and skeleton. Used to study medulloblastoma and pulmonary emphysema. Human ortholog(s) of this gene implicated in basal cell carcinoma; hepatocellular carcinoma; malignant pleural mesothelioma; pancreatic cancer; and pancreatic ductal carcinoma. Orthologous to human SMO (smoothened, frizzled class receptor).
epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in increased expression of SMO mRNA] and epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in increased expression of SMO protein]
[[Defoliants and Chemical results in increased abundance of Agent Orange] which results in increased abundance of Tetrachlorodibenzodioxin] which results in decreased methylation of SMO gene
[goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in increased expression of SMO protein] and goralatide inhibits the reaction [Silicon Dioxide results in increased expression of SMO protein]
[goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in increased expression of SMO protein] and goralatide inhibits the reaction [AGT protein results in increased expression of SMO protein]
[Arsenic Trioxide co-treated with Curcumin] inhibits the reaction [Cisplatin results in increased expression of SMO mRNA] and Arsenic Trioxide inhibits the reaction [Cisplatin results in increased expression of SMO mRNA]
[goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in increased expression of SMO protein] and Captopril inhibits the reaction [Silicon Dioxide results in increased expression of SMO protein]
Cisplatin promotes the reaction [jinfukang results in increased expression of SMO mRNA] and jinfukang promotes the reaction [Cisplatin results in increased expression of SMO mRNA]
[Clofibrate co-treated with Acetaminophen] affects the expression of SMO mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SMO mRNA]
[Arsenic Trioxide co-treated with Curcumin] inhibits the reaction [Cisplatin results in increased expression of SMO mRNA] and Curcumin inhibits the reaction [Cisplatin results in increased expression of SMO mRNA]
[Arsenic Trioxide co-treated with Curcumin] inhibits the reaction [Cisplatin results in increased expression of SMO mRNA] and Arsenic Trioxide inhibits the reaction [Cisplatin results in increased expression of SMO mRNA]
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMO mRNA
[goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in increased expression of SMO protein] and goralatide inhibits the reaction [Silicon Dioxide results in increased expression of SMO protein]
[goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in increased expression of SMO protein] and goralatide inhibits the reaction [AGT protein results in increased expression of SMO protein]
hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of SMO mRNA] and hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of SMO protein]
[mono-(2-ethylhexyl)phthalate co-treated with Androgens deficiency] results in increased expression of SMO mRNA and mono-(2-ethylhexyl)phthalate inhibits the reaction [cyclopamine results in increased expression of SMO mRNA]
[Clofibrate co-treated with Acetaminophen] affects the expression of SMO mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SMO mRNA]
tetramethylpyrazine inhibits the reaction [Paraquat results in increased expression of SMO mRNA] and tetramethylpyrazine inhibits the reaction [Paraquat results in increased expression of SMO protein]
hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of SMO mRNA] and hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of SMO protein]
cyclopamine inhibits the reaction [resveratrol results in increased expression of SMO protein] and resveratrol results in increased expression of and affects the localization of SMO protein
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMO mRNA
cyclopamine inhibits the reaction [Sodium Fluoride results in increased expression of SMO mRNA] and cyclopamine inhibits the reaction [Sodium Fluoride results in increased expression of SMO protein]
GANT 61 inhibits the reaction [Carbon Tetrachloride results in increased expression of SMO mRNA] and GANT 61 inhibits the reaction [Carbon Tetrachloride results in increased expression of SMO protein]
tetramethylpyrazine inhibits the reaction [Paraquat results in increased expression of SMO mRNA] and tetramethylpyrazine inhibits the reaction [Paraquat results in increased expression of SMO protein]
theaflavin inhibits the reaction [Diethylnitrosamine results in increased expression of SMO mRNA] and theaflavin inhibits the reaction [Diethylnitrosamine results in increased expression of SMO protein]
Expression of hedgehog signal pathway in articular cartilage is associated with the severity of cartilage damage in rats with adjuvant-induced arthritis.
Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.
Effective targeting of Hedgehog signaling in a medulloblastoma model with PF-5274857, a potent and selective Smoothened antagonist that penetrates the blood-brain barrier.
Association between donor and recipient smoothened gene polymorphisms and the risk of hepatocellular carcinoma recurrence following orthotopic liver transplantation in a Han Chinese population.